http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107141287-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate | 2016-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107141287-B |
| titleOfInvention | 2-imine-5-keto-2, 5-dihydro-1-H-dipyridopyrimidine compounds |
| abstract | The invention provides a 2-imine-5-keto-2, 5-dihydro-1-H-dipyridyl [3,4-c:1',2' -f]The invention discloses a synthesis method and application of a pyrimidine compound, and particularly discloses a compound shown as a general formula (I), and pharmaceutically acceptable salt or pharmaceutically acceptable solvate thereof, wherein the definition of each group is described in the specification. The compound of the invention can be used as an inhibitor targeting SPOP, or can be used for preparing a medicament for treating and/or preventing diseases (such as kidney cancer and the like) targeting SPOP. |
| priorityDate | 2016-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.